Urine concentrations of repetitive doses of inhaled salbutamol

J Elers; Lars Pedersen; J Henninge; P Hemmersbach; K Dalhoff; V Backer

doi:10.1055/s-0031-1273755

Urine concentrations of repetitive doses of inhaled salbutamol

J Elers, Lars Pedersen, J Henninge, P Hemmersbach, K Dalhoff, V Backer

Institut for Klinisk Medicin

10 Citationer (Scopus)

Abstract

We examined blood and urine concentrations of repetitive doses of inhaled salbutamol in relation to the existing cut-off value used in routine doping control. We compared the concentrations in asthmatics with regular use of beta2-agonists prior to study and healthy controls with no previous use of beta2-agonists. We enrolled 10 asthmatics and 10 controls in an open-label study in which subjects inhaled repetitive doses of 400 microgram salbutamol every second hour (total 1600 microgram), which is the permitted daily dose by the World Anti-Doping Agency (WADA). Blood samples were collected at baseline, 30 min, 1, 2, 3, 4, and 6 h after the first inhalations. Urine samples were collected at baseline, 0-4 h, 4-8 h, and 8-12 h after the first inhalations. Median urine concentrations peaked in the period 4-8 h after the first inhalations in the asthmatics and between 8-12 h in controls and the median ranged from 268 to 611 ng×mL (-1). No samples exceeded the WADA threshold value of 1000 ng×mL (-1) when corrected for the urine specific gravity. When not corrected one sample exceeded the cut-off value with urine concentration of 1082 ng×mL (-1). In conclusion we found no differences in blood and urine concentrations between asthmatic and healthy subjects. We found high variability in urine concentrations between subjects in both groups. The variability between subjects was still present after the samples were corrected for urine specific gravity.

Originalsprog	Engelsk
Tidsskrift	International Journal of Sports Medicine
Vol/bind	32
Udgave nummer	8
Sider (fra-til)	574-9
Antal sider	6
ISSN	0172-4622
DOI	https://doi.org/10.1055/s-0031-1273755
Status	Udgivet - 1 aug. 2011

Adgang til dokumentet

10.1055/s-0031-1273755

Citationsformater

@article{0df58625fd7e4d849632f4ce2a69cb2c,

title = "Urine concentrations of repetitive doses of inhaled salbutamol",

abstract = "We examined blood and urine concentrations of repetitive doses of inhaled salbutamol in relation to the existing cut-off value used in routine doping control. We compared the concentrations in asthmatics with regular use of beta2-agonists prior to study and healthy controls with no previous use of beta2-agonists. We enrolled 10 asthmatics and 10 controls in an open-label study in which subjects inhaled repetitive doses of 400 microgram salbutamol every second hour (total 1600 microgram), which is the permitted daily dose by the World Anti-Doping Agency (WADA). Blood samples were collected at baseline, 30 min, 1, 2, 3, 4, and 6 h after the first inhalations. Urine samples were collected at baseline, 0-4 h, 4-8 h, and 8-12 h after the first inhalations. Median urine concentrations peaked in the period 4-8 h after the first inhalations in the asthmatics and between 8-12 h in controls and the median ranged from 268 to 611 ng×mL (-1). No samples exceeded the WADA threshold value of 1000 ng×mL (-1) when corrected for the urine specific gravity. When not corrected one sample exceeded the cut-off value with urine concentration of 1082 ng×mL (-1). In conclusion we found no differences in blood and urine concentrations between asthmatic and healthy subjects. We found high variability in urine concentrations between subjects in both groups. The variability between subjects was still present after the samples were corrected for urine specific gravity.",

author = "J Elers and Lars Pedersen and J Henninge and P Hemmersbach and K Dalhoff and V Backer",

note = "{\textcopyright} Georg Thieme Verlag KG Stuttgart · New York.",

year = "2011",

month = aug,

day = "1",

doi = "10.1055/s-0031-1273755",

language = "English",

volume = "32",

pages = "574--9",

journal = "International Journal of Sports Medicine",

issn = "0172-4622",

publisher = "GeorgThieme Verlag",

number = "8",

}

TY - JOUR

T1 - Urine concentrations of repetitive doses of inhaled salbutamol

AU - Elers, J

AU - Pedersen, Lars

AU - Henninge, J

AU - Hemmersbach, P

AU - Dalhoff, K

AU - Backer, V

PY - 2011/8/1

Y1 - 2011/8/1

N2 - We examined blood and urine concentrations of repetitive doses of inhaled salbutamol in relation to the existing cut-off value used in routine doping control. We compared the concentrations in asthmatics with regular use of beta2-agonists prior to study and healthy controls with no previous use of beta2-agonists. We enrolled 10 asthmatics and 10 controls in an open-label study in which subjects inhaled repetitive doses of 400 microgram salbutamol every second hour (total 1600 microgram), which is the permitted daily dose by the World Anti-Doping Agency (WADA). Blood samples were collected at baseline, 30 min, 1, 2, 3, 4, and 6 h after the first inhalations. Urine samples were collected at baseline, 0-4 h, 4-8 h, and 8-12 h after the first inhalations. Median urine concentrations peaked in the period 4-8 h after the first inhalations in the asthmatics and between 8-12 h in controls and the median ranged from 268 to 611 ng×mL (-1). No samples exceeded the WADA threshold value of 1000 ng×mL (-1) when corrected for the urine specific gravity. When not corrected one sample exceeded the cut-off value with urine concentration of 1082 ng×mL (-1). In conclusion we found no differences in blood and urine concentrations between asthmatic and healthy subjects. We found high variability in urine concentrations between subjects in both groups. The variability between subjects was still present after the samples were corrected for urine specific gravity.

AB - We examined blood and urine concentrations of repetitive doses of inhaled salbutamol in relation to the existing cut-off value used in routine doping control. We compared the concentrations in asthmatics with regular use of beta2-agonists prior to study and healthy controls with no previous use of beta2-agonists. We enrolled 10 asthmatics and 10 controls in an open-label study in which subjects inhaled repetitive doses of 400 microgram salbutamol every second hour (total 1600 microgram), which is the permitted daily dose by the World Anti-Doping Agency (WADA). Blood samples were collected at baseline, 30 min, 1, 2, 3, 4, and 6 h after the first inhalations. Urine samples were collected at baseline, 0-4 h, 4-8 h, and 8-12 h after the first inhalations. Median urine concentrations peaked in the period 4-8 h after the first inhalations in the asthmatics and between 8-12 h in controls and the median ranged from 268 to 611 ng×mL (-1). No samples exceeded the WADA threshold value of 1000 ng×mL (-1) when corrected for the urine specific gravity. When not corrected one sample exceeded the cut-off value with urine concentration of 1082 ng×mL (-1). In conclusion we found no differences in blood and urine concentrations between asthmatic and healthy subjects. We found high variability in urine concentrations between subjects in both groups. The variability between subjects was still present after the samples were corrected for urine specific gravity.

U2 - 10.1055/s-0031-1273755

DO - 10.1055/s-0031-1273755

M3 - Journal article

SN - 0172-4622

VL - 32

SP - 574

EP - 579

JO - International Journal of Sports Medicine

JF - International Journal of Sports Medicine

IS - 8

ER -

Urine concentrations of repetitive doses of inhaled salbutamol

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater